isoguvacine has been researched along with Prostatic Hyperplasia in 1 studies
isoguvacine: A GABA agonist; RN given refers to parent cpd; structure
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdul, M | 1 |
| Mccray, SD | 1 |
| Hoosein, NM | 1 |
1 other study available for isoguvacine and Prostatic Hyperplasia
| Article | Year |
|---|---|
Expression of gamma-aminobutyric acid receptor (subtype A) in prostate cancer.
Topics: Bicuculline; Cell Proliferation; Colonic Neoplasms; Dihydroergotoxine; GABA Agonists; GABA Antagonis | 2008 |